Funder: Pershing Square Philanthropies
Due Dates (Anticipated): September 2026: Letter of Intent deadline (projected)
Funding Amounts: $750,000 total over 3 years ($250,000/year; max 10% indirect costs)
Summary: Supports innovative, high-risk neuroscience research on neurodegenerative diseases, empowering early-to-mid-career investigators to pursue bold, interdisciplinary projects.
Key Information: Only one LOI per PI per cycle; max three applications per PI lifetime.